nifedipine has been researched along with mebudipine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, S; Chang, CC; Dunne, SF; Kai, L; Kang, S; Luan, CH; Pandey, P; Silverman, RB; Surmeier, DJ; Tian, X | 1 |
| Ghiaee, S; Mahmoudian, M; Mirkhani, H; Nehardani, Z | 1 |
| Ghiaee, S; Mahmoudian, M; Mirkhani, H; Omrani, GR | 1 |
| Faizi, M; Janahmadi, M; Mahmoudian, M | 1 |
| Bohlooli, S; Keyhanfar, F; Mahmoudian, M | 1 |
| Beigly, S; Ebrahimi, SA; Ghiaee, S; Mahmoudian, M | 1 |
| Bohlooli, S; Grant, MH; Mahmoudian, M; Skellern, GG; Tettey, JN | 1 |
| Dirin, M; Mirkhani, H; Youssef-Zayeh, I | 1 |
| Ebrahimi, SA; Mahmoudian, M; Rahbr-Roshandel, N; Rouzrokh, A | 1 |
| Mahmoudian, M; Rahbar-Roshandel, N; Rahimi-Moghaddam, P; Tavakoli-Far, B | 1 |
| Mahmoudian, M; Sepehr-Ara, L; Sepehr-Ara, M | 1 |
| Keyhanfar, F; Khani, S | 1 |
| Amani, A; Keyhanfar, F; Khani, S | 1 |
| Badalzadeh, R; Ghiasi, A; Ghiasi, R; Majidinia, M; Mohammadi, M; Yousefi, B | 1 |
| Abbasi, S; Amani, A; Keyhanfar, F; Khani, S | 1 |
| Aali, E; Ghaznavi, H; Mahmoudian, M; Shafiei, M; Soltanpour, MS | 1 |
16 other study(ies) available for nifedipine and mebudipine
| Article | Year |
|---|---|
Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels Ca V 1.3 and Ca V 1.2.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Dicarboxylic Acids; Dihydropyridines; Humans; Inhibitory Concentration 50; Molecular Structure; Nifedipine | 2010 |
Synthesis and biological activity of two new calcium-channel blockers, mebudipine and dibudipine.
Topics: Animals; Aorta, Thoracic; Calcium; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Ileum; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Molecular Structure; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nifedipine; Potassium; Rats | 1997 |
Effects of mebudipine and dibudipine, two new calcium-channel blockers, on rat left atrium, rat blood pressure and human internal mammary artery.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Heart Atria; Humans; Male; Mammary Arteries; Nifedipine; Rats; Rats, Sprague-Dawley | 1999 |
The effect of mebudipine and dibudipine, two new Ca2+ channel blockers, in comparison with nifedipine on Ca2+ spikes of F1 neuronal soma membrane in Helix aspersa.
Topics: 4-Aminopyridine; Analysis of Variance; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Dose-Response Relationship, Drug; Electrophysiology; Esophagus; Helix, Snails; Membrane Potentials; Neurons; Nifedipine; Patch-Clamp Techniques | 2003 |
Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Calcium Channel Blockers; Half-Life; Injections, Intravenous; Male; Metabolic Clearance Rate; Nifedipine; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2004 |
Effects of mebudipine and dibudipine, two new calcium channel blockers, on guinea-pig isolated common bile duct.
Topics: Animals; Calcium Channel Blockers; Common Bile Duct; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Parasympatholytics | 2004 |
Metabolism of the dihydropyridine calcium channel blockers mebudipine and dibudipine by isolated rat hepatocytes.
Topics: Angina Pectoris; Animals; Cell Culture Techniques; Half-Life; Hepatocytes; Hydroxylation; Hypertension; Male; Nifedipine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 2004 |
Mechanism of vasoselective action of mebudipine, a new calcium channel blocker.
Topics: Animals; Aorta, Thoracic; Calcium Channel Blockers; Calcium Channels; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Combinations; Heart Atria; Heart Rate; Male; Membrane Potentials; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Time Factors; Vasoconstriction; Vasodilation | 2004 |
Effects of mebudipine and dibudipine, two new calcium channel blockers on voltage-activated calcium currents of PC12 cells.
Topics: Amlodipine; Animals; Barium Compounds; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Differentiation; Chlorides; Dose-Response Relationship, Drug; Membrane Potentials; Nerve Growth Factor; Neurons; Nifedipine; PC12 Cells; Rats | 2007 |
Neuroprotective effects of mebudipine and dibudipine on cerebral oxygen-glucose deprivation/reperfusion injury.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Dizocilpine Maleate; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Formazans; Glucose; Hypoxia; Mice; N-Methylaspartate; Neurons; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Quinoxalines; Receptors, Kainic Acid; Reperfusion Injury; Tetrazolium Salts; Time Factors | 2009 |
Effect of the two new calcium channel blockers mebudipine and dibudipine in comparison to amlodipine on vascular flow of isolated kidney of diabetic rat.
Topics: Amlodipine; Animals; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; Nifedipine; Rats; Rats, Wistar; Renal Circulation | 2010 |
Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF).
Topics: Absorption; Administration, Oral; Animals; Biological Availability; Chemistry, Pharmaceutical; Fructose; Male; Nifedipine; Oils; Particle Size; Phospholipids; Rats; Rats, Wistar; Solubility; Solutions; Suspensions; Triglycerides | 2014 |
Design and evaluation of oral nanoemulsion drug delivery system of mebudipine.
Topics: Administration, Oral; Animals; Biological Availability; Calcium Channel Blockers; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Stability; Emulsions; Nanoparticles; Nifedipine; Polysorbates; Rats; Solubility; Solutions | 2016 |
The effects of mebudipine on myocardial arrhythmia induced by ischemia-reperfusion injury in isolated rat heart.
Topics: Animals; Arrhythmias, Cardiac; Creatine Kinase; Heart; Heart Rate; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardium; Nifedipine; Protective Agents; Rats; Rats, Wistar; Reperfusion Injury; Tachycardia, Ventricular; Ventricular Fibrillation | 2016 |
Use of artificial neural networks for analysis of the factors affecting particle size in mebudipine nanoemulsion.
Topics: Emulsions; Ethanol; Hexoses; Nanoparticles; Neural Networks, Computer; Nifedipine; Oleic Acids; Particle Size; Polyethylene Glycols; Polysorbates; Surface-Active Agents; Water | 2019 |
Cardioprotective Effects of Mebudipine in a Rat Model of Doxorubicin-Induced Heart Failure.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Doxorubicin; Heart; Heart Failure; Heart Rate; Iran; Nifedipine; Protective Factors; Rats; Rats, Wistar | 2021 |